Where does ViaCyte, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ViaCyte, Inc. ranks #4,854 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ViaCyte, Inc. hold?

ViaCyte, Inc. holds 72 US utility patents granted between 2015 and 2025, spanning 14 technology areas.

What is ViaCyte, Inc.'s Innovation Score?

ViaCyte, Inc. has an Innovation Score of 41.6 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is ViaCyte, Inc.'s patent grant rate increasing or decreasing?

ViaCyte, Inc.'s recent grant velocity is -49% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for ViaCyte, Inc.'s patents?

ViaCyte, Inc.'s patents average 11.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ViaCyte, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

ViaCyte, Inc.

Q: What technology areas does ViaCyte, Inc. focus on?

ViaCyte, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 51 patents, ranking #192 of 4,144 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

USPTO PatentsView assignee record - 72 granted patents across 14 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Viacyte ranks #4,854 of 49,997 tracked US assignees by granted-patent volume, with 72 patents across 14 technology areas.

#4,854
of 49,997 US assignees by volume: Top 33%
by Innovation Score (41.6/100): 11.4
avg claims per patent: -49%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4854 · US Corporation #4,854 · 72 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 72 grants
TOP-DECILE #4,854/49,997
PHOTO-FINISH kaleo
CPC-FOCUS C12N · 14 areas
INNOV-PAR 41.6/100
CLAIMS-PAR 11.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -49% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: kaleo, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Viacyte’s 41.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.8 pts (36%) Velocity 6.7 pts (16%) Breadth 13.2 pts (32%) Claim depth 6.8 pts (16%)

Qualcomm Incorporated · highest

85
Ashimori Industry · near

42
D-box · near

42
Lumileds Holding B V · near

42
Optodot · near

42
ViaCyte · this assignee

42
3D Lighting… · lowest

7

What this shows Viacyte's Innovation Score is 41.6/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Viacyte?

Each dot is one of Viacyte’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Viacyte’s own 11.4 claims/patent is at or below the 16.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Viacyte vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Viacyte's grants concentrate

ViaCyte, Inc. is a focused PatentsView assignee: 14 CPC subclasses with 70.8% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2016 (16 grants) versus a trough of 3 in 2021. By volume, Viacyte sits between University OF Copenhagen and Advanced Digital Broadcast S.A..

Viacyte's three-year grant acceleration

ViaCyte, Inc. shows 16 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

University OF Cop…

72
Unity IPR Aps

72
Valent Biosciences

72
Vehicle Energy Ja…

72
Wilcox Industries

72
Xiamen San'an Opt…

72
kaleo

72
Viacyte ◀

72
Advanced Digital…

71

What this shows ViaCyte holds 72 patents at rank #4,853, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ViaCyte

By rank, the assignees closest to #4,853 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in ViaCyte's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for ViaCyte, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), ViaCyte ranks #192 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Lumileds Holding B.V. 42 Ashimori Industry Co., Ltd. 42 D-box Technologies Inc. 42 Optodot Corporation 42

Similar claim depth

Nearest assignees by average claims per patent (11.4 here).

Institute of Automation, Chinese Academy of Sciences 11.4 avg Tosoh Corporation 11.4 avg Goertek Inc. 11.4 avg Furukawa Electric Co., Ltd. 11.4 avg

Viacyte's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 33% higher than 67% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

ViaCyte, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	12.5%
2016	16	22.2%
2017	5	6.9%
2018	6	8.3%
2019	9	12.5%
2020	4	5.6%
2021	3	4.2%
2022	4	5.6%
2023	5	6.9%
2024	7	9.7%
2025partial year	4	5.6%

Which technologies does ViaCyte, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 51

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 24

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 16

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 13

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 12

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 8

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 6

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 4

C07K - Peptides 3

Y02A - Technologies FOR Adaptation TO Climate Change 2

A61B - DIAGNOSIS; SURGERY; Identification 2

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ViaCyte, Inc.'s patent record in context - here's where to go next.

ViaCyte, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 70.8% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #4,854 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ViaCyte, Inc. against University OF Copenhagen, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.